OpenFilings

Avalo Therapeutics, Inc.

Form10-Q

Report Period2026-06-30

Date Filed2026-08-06

Time Filed07:03:55

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
EX-10.5
EX-10.6
EX-21.1
EX-31.1
EX-31.2
EX-32.1
Filing on SEC Edgar